Filing Flows › Biofrontera (BFRI) › Who owns the stock
Who owns Biofrontera (BFRI) stock
17 funds reported Biofrontera (BFRI) shares in their latest 13F filings, worth $3.5M in all. The largest holder is Aigh Capital Management LLC ($1.6M). Last quarter 9 funds added to their stakes and 6 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Aigh Capital Management LLC | 1,496,583 | $1.6M | increase | 2026-09-30 |
| Rosalind Advisors | 1,275,609 | $1.2M | increase | 2026-06-30 |
| Renaissance Technologies LLC | 157,505 | $149K | new | 2026-06-30 |
| Citadel Advisors LLC | 104,941 | $99K | new | 2026-06-30 |
| Jane Street Group, LLC | 93,000 | $88K | new | 2026-06-30 |
| Geode Capital Management, LLC | 76,689 | $73K | decrease | 2026-06-30 |
| Vanguard Capital Management LLC | 71,380 | $68K | increase | 2026-06-30 |
| Vanguard Group | 113,951 | $65K | unchanged | 2025-12-31 |
| Vanguard Fiduciary Trust | 61,697 | $58K | unchanged | 2026-06-30 |
| XTX Topco | 51,894 | $49K | increase | 2026-06-30 |
| Northern Trust | 31,536 | $30K | new | 2026-06-30 |
| UBS Group AG | 18,518 | $18K | increase | 2026-06-30 |
| Jones Financial Companies Lllp | 10,000 | $10K | new | 2026-06-30 |
| GSA Capital Partners LLP | 10,022 | $9K | new | 2026-06-30 |
| BlackRock | 4,622 | $4K | unchanged | 2026-06-30 |
Biofrontera's latest quarter
Biofrontera, Q2 2026: revenue $12.0M (+33% year over year), operating margin -4.4%, net loss $604K, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most BFRI stock?
By the latest 13F filings: Aigh Capital Management LLC ($1.6M); Rosalind Advisors ($1.2M); Renaissance Technologies LLC ($149K); Citadel Advisors LLC ($99K); Jane Street Group, LLC ($88K).
What is the short interest in BFRI?
103,148 shares were sold short at the 2026-10-15 settlement, -29.76% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.